Abadie D, Durrieu G, Roussin G, Montastruc JL. Effets indésirables "graves" du tramadol : bilan 2010-2011 de pharmacovigilance en France. Thérapie 2013, 68, 77-84.

Amar J, Lieber A, Montastruc F, Bagheri H, Pathak A, Montastruc JL. Arterial hypertension and resistance to antihypertensive treatment : a new adverse drug reaction with Modafinil. Therapie 2013, 68, 53-4.

Bezzina C, Bondon-Guitton E, Montastruc JL. Inhaled corticosteroid-induced hair depigmentation in a child. J Drugs Dermatol. 2013, 1, 119-20.

Castel M, Despas F, Modesto A, Gales C, Honton B, Galinier M, Senard JM, Pathak A. Cardiotoxicity of chemotherapies. Presse Med. 2013 Jan ;42(1):26-39. French.

Chavant F, Ingrand I, Jonville-Bera AP, Plazanet C, Gras-Champel V, Lagarce L, Zenut M, Disson-Dautriche A, Logerot S, Auffret M, Coubret-Dumas A, Bruel ML, Boyer M, Bos-Thompson MA, Veyrac G, Carlier P, Beyens MN, Lates S, Damase-Michel C, Castot A, Kreft-Jaus C, Pérault-Pochat MC. The PREGVAXGRIP study : a cohort study to assess foetal and neonatal consequences of in utero exposure to vaccination against A(H1N1)V2009 influenza. Drug saf 2013, 36,

Damase-Michel C, Hurault-Delarue C. Ibuprofen does not seem to increase global malformation risk but NSAID use in late pregnancy remains a concern. Evid Based Med doi:10.1136/eb-2013-101495

Danton AC, Montastruc F, Sommet A, Durrieu G, Bagheri H, Bondon-Guitton E, Lapeyre-Mestre M, Montastruc JL. Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug-drug interactions : a pharmacovigilance study in France. Eur J Clin Pharmacol 2013, 69,885-888.

Durrieu G, Mazau B, Jégu J, Lapeyre-Mestre M, Delord JP, Montastruc JL. Drugs and cancer : an analysis of the french pharmacoviiglance database. Thérapie 2013, 68, 149-54.

Faillie JL, Petit P, Montastruc JL, Hillaire-Buys D. Scientific evidence and controversies about pioglitazone and bladder cancer : which lessons can be drawn ? Drug Saf 2013, 36, 693-707.

Faye E, Bondon-Guitton E, Olivier-Abbal P, Montastruc JL, Spontaneous reporting of serious cutaneous reactions with protein kinase inhibitors. Eur J Clin Pharmacol 2013, 69, 1819-26.

Fuzier R, Serres I, Guitton E, Lapeyre-Mestre M, Montastruc JL ; French Network of Pharmacovigilance Centres. Adverse drug reactions to gabapentin and pregabalin : a review of the French pharmacovigilance database. Drug Saf 2013, 36, 55-62.

Gulmez SE, Larrey D, Pageaux GP, Lignot S, Lassalle R, Jové J, Gatta A, McCormick PA, Metselaar HJ, Monteiro E, Thorburn D, Bernal W, Zouboulis-Vafiadis I, de Vries C, Perez-Gutthann S, Sturkenboom M, Bénichou J, Montastruc JL, Horsmans Y, Salvo F, Hamoud F, Micon S, Droz-Perroteau C, Blin P, Moore N. Transplantation for acute liver failure in patients axposed to NSAIDs or paracetamol (Acetaminophen) : the multinational case-population SALT study. Drug Saf. 2013, 36, 135-44.

Gulmez SE, Moore N, Pageaux GP, Lignot S, Horsmans Y, Stricker B, Bernuau J, Bissoli F, Thorburn D, Montastruc JL, Micon S, Hamoud F, Lassalle R, Jové J, Blin P, Larrey D. Causality of Drugs Involved in Acute Liver Failure Leading to Transplantation : Results from the Study of Acute Liver Transplant (SALT). Drug Saf 2013, 36, 757-64.

Lapeyre-Mestre M, Grolleau S, Montastruc JL. Adverse drug reactions associated with the use of NSAIDS : a case/non case analysis of spontaneous reports from the french pharmacovigilance database 2002-2006. Fundam Clin Pharmacol 2013, 27, 223-230.

Laroche ML, Perault-Pochat MC, Ingrand I, Merle L, Kreft-Jais C, Casto-Villepelet A, Durrieu G, Gras V, Guy C, Jean-Pastor MJ, Jonville-Béra AP, Merlet-Chicoine I, Miremont-Salamé G, Nourashemi F, Charmes JP. Adverse drug reactions in patients with Alzheimer’s disease and related dementia in France : a national multicentre cross-sectional study. Pharmacoepidemiol Drug Saf 2013, 22, 952-60.

Le Lay M, Fournier JP, Montastruc JL. Interactions médicamenteuses potentielles en médecine générale : comparaison de deux études transversales en 1997 et 2012. Thérapie 2013, 68 , 411-3.

Mintzes B, Lexchin J, Sutherland JM, Beaulieu MD, Wilkes MS, Durrieu G, Reynolds E. Pharmaceutical sales representatives and patient safety : a comparative prospective study of information quality in Canada, France and the United States. J Gen Med Intern 2013 ; 28, 1368-75.

Montastruc F, Gardette V, Cantet C, Piau A, Lapeyre-Mestre M, Vellas B, Montastruc JL, Andrieu S. Potentially inappropriate medication use among patients with Alzheimer disease in the REALFR cohort : be aware of atropinic and benzodiazepine drugs ! Eur J Clin Pharmacol 2013, 69, 1589-97.

Montastruc F, Laffont M, Bagheri H, Montastruc JL. Potentially inappropriate medications in the elderly in France : a study in community pharmacies in 2011-2012. Eur J Clin Pharmacol 2013, 69, 741-2.

Montastruc F, Schmitt L, Montastruc JL, Pathak A. QT interval and antidepressant use : a cross sectional study of electronic health records. BMJ 2013 ;346:f288 doi : 10.1136/bmj.f288

Montastruc JL, Laffon de Mazières C, Montastruc F, Moulis G. Réflexions éthiques après l’affaire du Médiator°. Bioethique.com/index. 27 novembre 2013.

Moulis G, Sommet A, Béné J, Montastruc F, Sailler L, Montastruc JL, Lapeyre-Mestre M. Cancer risk on anti-TNF-a at recommended doses in adult rheumatoid arthritis : a meta-analysis with intention to treat and per protocol analyses. Plos One 2013, DOI : 10.1371.

Moulis G, Sommet A, Lapeyre-Mestre M, Montastruc JL. Is the risk of tumor necrosis factor inhibitor-induced lupus the same with monoclonal antibodies and soluble receptor ? A case/non case study in a nationwide pharmacovigilance database. Arthritis Rheum 2013, 65, 612-3.

Olivier-Abbal P, Teisseyre AC, Montastruc JL. Comparison of serious adverse reactions between thalidomide and lenalidomide : analysis in the French pharmacovigilance database. Med Oncol 2013, 30, 733.

Orriols L, Foubert-Samier A, Gadegbeku B, Delorme B, Tricotel A, Philip P, Moore N, Lagarde E, CESIR Research Group. Prescription of antiepileptics and the risk of road traffic crash. J Clin Pharmacol 2013, 53, 339-44.

Sommet A, Georgel B, Poutrain JC, Oustric S, Bourrel R, Montastruc JL, Birebent J. Différence de taux de substitution des médicaments génériques en Midi-Pyrénées en fonction des classes pharmaco-thérapeutiques. Rev Epidémiol Sant Pub 2013, 61, 539-44.